Effectiveness and safety of a model predictive control (MPC) algorithm for an artificial pancreas system in outpatients with type 1 diabetes (T1D): systematic review and meta-analysis

[1] Brawerman G(2020)Beta cell therapies for preventing type 1 diabetes: from bench to bedside Biomoleculs 10 1-20

[2] Thompson PJ(2015)Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D exchange clinic registry Diabetes Care 38 971-978

[3] Miller KM(2013)Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D exchange clinic registry Endocr Res 98 3411-3419

[4] Foster NC(2021)Hypoglycemia in diabetes: an update on pathophysiology, treatment, and prevention World J Diabetes 12 2036-2049

[5] Beck RW(2019)6. Glycemic targets: standards of medical care in diabetes-2019 Diabetes Care. 42 S61-70

[6] Weinstock RS(1993)The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus New England J Med 329 977-986

[7] Xing D(2021)Current treatment options and challenges in patients with Type 1 diabetes: pharmacological, technical advances and future perspectives Rev Endocr Metab Disord 22 217-240

[8] Maahs DM(2010)Sensor-augmented pump therapy—on the way to artificial pancreas Avances en Diabetología 26 143-6

[9] Nakhleh A(2010)Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes N Engl J Med 363 311-320

[10] Shehadeh N(2010)Evolution of diabetes insulin delivery devices J Diabetes Sci Technol 4 505-513

[1] Brawerman G(2020)Beta cell therapies for preventing type 1 diabetes: from bench to bedside Biomoleculs 10 1-20

[2] Thompson PJ(2015)Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D exchange clinic registry Diabetes Care 38 971-978

[3] Miller KM(2013)Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D exchange clinic registry Endocr Res 98 3411-3419

[4] Foster NC(2021)Hypoglycemia in diabetes: an update on pathophysiology, treatment, and prevention World J Diabetes 12 2036-2049

[5] Beck RW(2019)6. Glycemic targets: standards of medical care in diabetes-2019 Diabetes Care. 42 S61-70

[6] Weinstock RS(1993)The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus New England J Med 329 977-986

[7] Xing D(2021)Current treatment options and challenges in patients with Type 1 diabetes: pharmacological, technical advances and future perspectives Rev Endocr Metab Disord 22 217-240

[8] Maahs DM(2010)Sensor-augmented pump therapy—on the way to artificial pancreas Avances en Diabetología 26 143-6

[9] Nakhleh A(2010)Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes N Engl J Med 363 311-320

[10] Shehadeh N(2010)Evolution of diabetes insulin delivery devices J Diabetes Sci Technol 4 505-513